doi:10.3969/j.issn.1671-2587.2019.05.003

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (5): 458-461.DOI: 10.3969/j.issn.1671-2587.2019.05.003

Previous Articles Next Articles

Received:2018-02-11 Online:2019-10-20 Published:2019-10-29

1 李欣瑜,黄科,周敦华,等.地拉罗司与去铁胺治疗输血依赖型地中海贫血铁过载的效果分析[J].儿科药学杂志,2017,23(9):8-11.
2 A Pepe,A Meloni,G Rossi,et al.Cardiac and hepatic iron and ejection fraction in thalassemia major:multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy[J].J Cardiovasc Magn Reson,2013,15(1):1.
3 Karami H,Kosaryan M,Amree A H,et al.Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent beta-Thalassemia Major[J].Clin Pract,2017,7(1):912.
4 E Cassinerio,N Orofino,A Roghi,et al.Combination of deferasirox and deferoxamine in clinical practice:an alternative scheme of chelation in thalassemia major patients[J]. Blood Cells Mol Dis,2014,53(3):164-167.
5 Angelucci E,Brittenham G M,McLaren C E,et al.Hepatic iron concentration and total body iron stores in thalassemia major[J].N Engl J Med,2000,343(22):327-331.
6 A Tanphaichitr,T Kusuwan,S Limviriyakul,et al.Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents[J].Hemoglobin,2014,38(5):345-350.
7 E Voskaridou,V Komninaka,A Karavas,et al.Combination therapy of deferasirox and deferoxamine shows significant improvements in markers of iron overload in a patient with beta-thalassemia major and severe iron burden[J].Transfusion,2014,54(3):646-649.
8 郑晴晴,常春康.铁过载相关机制的研究在MDS中的重要意义[J].中国实验血液学杂志,2017,25(1):306-310.
9 刘华平,李文政,李海兰,等.磁共振成像技术在肝脏铁过载的应用进展[J].磁共振成像,2017,8(6):475-480.
10 ES Hatzipantelis,K Karasmanis,V Perifanis,et al.Combined chelation therapy with deferoxamine and deferiprone in beta-thalassemia major:compliance and opinions of young thalassemic patients[J]. Hemoglobin,2014,38(2):111-114.
11 Elalfy,A M Adly,Y Wali,et al.Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients[J].Eur J Haematol,2015,95(5):411-420.
12 M Gharagozloo,B Moayedi,M Zakerinia,et al.Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major:a randomized double-blind clinical trial[J].Fundam Clin Pharmacol,2009,23(3):359-365.
13 D Songdej,N Sirachainan,P Wongwerawattanakoon,et al.Combined chelation therapy with daily oral deferiprone and twice-weekly subcutaneous infusion of desferrioxamine in children with beta-thalassemia:3-year experience[J].Acta Haematol,2015,133(2):226-236.
14 A Lal,J Porter,N Sweeters,et al.Combined chelation therapy with deferasirox and deferoxamine in thalassemia[J].Blood Cells Mol Dis,2013,50(2):99-104.

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[3]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[4]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[5]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[6]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[7]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[8]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[13]	HAO Yi-wen. Evaluating Indications for Red Blood Cell Transfusion and Therapeutic Efficacy:An Overall and Dynamic View [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 590-593.
[14]	HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 613-616.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact